(A) SMC | (B) SUPPORT | (C) EXPECT | Test statistic (F scores indicate interaction terms) | Significant pre–post comparisons | |
---|---|---|---|---|---|
Disability (PDI) | |||||
Baseline | 22.78 (18.36–27.19) | 22.14 (17.04–27.23) | 25.89 (20.81–30.97) | F(2, 102.542) = 4.762; | B, C |
Follow-up | 20.79 (15.35–26.23) | 15.23 (10.82–19.65) | 12.19 (8.50–15.89) | P = 0.011 | |
Mental quality of life (SF-12) | |||||
Baseline | 48.96 (45.71–52.20) | 51.60 (48.56–54.63) | 47.98 (43.66–52.31) | F(2, 94.803) = 4.627; | C |
Follow-up | 50.58 (47.02–54.14) | 52.40 (48.83–55.97) | 56.74 (54.29–59.19) | P = 0.012 | |
Physical quality of life (SF-12) | |||||
Baseline | 40.26 (36.80–43.73) | 39.55 (35.82–43.29) | 37.15 (34.04–40.26) | F(2, 103.928) = 3.186; | B, C |
Follow-up | 40.28 (36.58–43.98) | 45.21 (41.23–49.19) | 44.77 (41.13–48.41) | P = 0.045 | |
Patient subjective working ability in hours per week follow-up | 15.97 (10.50–21.43) | 17.14 (10.45–23.80) | 25.40 (19.90–30.90) | F(2, 74) = 3.325; P = 0.041a | ACa, BCa |
Physical activity levels (IPAQ) | |||||
Baseline | 2668.40 (1919.56–3417.24) | 2635.54 (1547.50–3723.57) | 2433.63 (1249.51–3617.75) | F(2, 72.915) = 4.776; | B, C |
Follow-up | 2957.64 (2128.50–3786.78) | 5388.21 (3618.71–7157.71) | 4700.60 (3470.76–5930.45) | P = 0.011 | |
Cardiac anxiety (CAQ) | |||||
Baseline (pre-intervention) | 2.48 (2.29–2.67) | 2.68 (2.47–2.90) | 2.67 (2.44–2.89) | F(2, 107.021) = 3.980; | B, C |
Follow-up (after 6 months) | 2.50 (2.31–2.69) | 2.34 (2.11–2.57) | 2.29 (2.11–2.47) | P = 0.022 | |
Anxiety (HADS) | |||||
Baseline (pre-intervention) | 4.03 (3.07–4.98) | 4.55 (3.42–5.67) | 5.17 (3.47–6.86) | F(2,102.409) = 1.325; | |
Follow-up (after 6 months) | 3.24 (2.42–4.05) | 2.52 (1.52–3.51) | 3.61 (2.22–4.99) | P = 0.270 | |
Depression (HADS) | |||||
Baseline (pre-intervention) | 4.59 (3.60–5.58) | 4.00 (2.89–5.11) | 5.11 (3.75–6.47) | F(2, 99.211) = 2.604; | |
Follow-up (after 6 months) | 3.68 (2.62–4.75) | 1.88 (1.20–2.57) | 2.58 (1.60–3.56) | P = 0.079 | |
Outcome expectations (IPQ-E) | |||||
Baseline (pre-intervention) | 12.05 (11.49–12.62) | 12.61 (12.10–13.12) | 12.37 (11.90–12.83) | F(2, 98.882) = 0.084; P = 0.919 | |
Post psychological intervention | 11.94 (11.32–12.56) | 12.29 (11.97–12.60) | 12.09 (11.52–12.66) | ||
Expected personal control (IPQ-E) | |||||
Baseline (pre-intervention) | 15.28 (14.74–15.81) | 15.24 (14.55–15.92) | 14.03 (12.90–15.16) | F(2, 103.971) = 8.748; P < 0.001 | C |
Post psychological intervention | 15.16 (14.43–15.88) | 14.91 (14.13–15.68) | 16.06 (15.40–16.73) | ||
Patients rehospitalized after CABG, n (%)a | |||||
Follow-up | 9 (26.47) | 7 (23.33) | 3 (9.38) | χ 2 (2) = 3.380; P = 0.185 | |
LVEF, n (%) at follow-up | |||||
≥ 50 | 25 (80.6) | 23 (88.5) | 24 (100) | χ 2 (2) = 5.138; P = 0.077 | |
49–30 | 6 (19.4) | 3 (11.5) | 0 (0) | ||
< 30 | 0 (0) | 0 (0) | 0 (0) | ||
Interleukin-6 (pg/mL)a | |||||
Baseline (pre-intervention) | 3.71 (2.14–5.27) | 2.10 (1.34–2.86) | 3.58 (1.91–5.25) | F = (6, 216.924) =2.523; P = 0.022 | Follow-up: AC |
Post psychological intervention | 3.06 (2.03–4.10) | 1.83 (1.44–2.22) | 3.44 (2.07–4.82) | ||
After surgery | 24.75 (18.61–30.89) | 19.56 (13.63–25.49) | 19.90 (15.63–24.18) | ||
Follow-up (after 6 months) | 4.83 (2.99–6.68) | 3.66 (2.16–5.16) | 2.39 (1.38–3.41) | ||
Interleukin-8 (pg/mL) | |||||
Baseline (pre-intervention) | 5.48 (4.05–6.90) | 5.56 (4.33–6.79) | 5.78 (4.18–7.38) | F = (6, 206.632) = 4.186; P = 0.001 | Post-surgery: AB, AC |
Post psychological intervention | 4.76 (3.86–5.66) | 5.13 (3.89–6.38) | 5.52 (3.73–7.30) | ||
After surgery | 13.71 (11.44–15.97) | 10.31 (8.14–12.48) | 11.02 (8.64–13.40) | ||
Follow-up (after 6 months) | 5.08 (3.63–6.52) | 4.83 (4.22–5.45) | 6.07 (4.76–7.37) | ||
Tumor necrosis factor alpha (pg/mL)a | |||||
Baseline (pre-intervention) | 2.01 (1.60–2.42) | 1.48 (1.19–1.76) | 1.61 (1.39–1.83) | F(6, 174.813) = 1.404; P = 0.216 | |
Post psychological intervention | 2.20 (1.78–2.62) | 1.54 (1.32–1.76) | 1.72 (1.43–2.01) | ||
After surgery | 3.63 (2.72–4.54) | 2.17 (1.81–2.52) | 3.12 (2.51–3.72) | ||
Follow-up (after 6 months) | 2.66 (2.00–3.32) | 1.72 (1.48–1.96) | 2.09 (1.70–2.49) | ||
C-reactive protein (μg/mL)a | |||||
Baseline (pre-intervention) | 2.49 (1.84–3.15) | 2.23 (1.32–3.15) | 2.96 (2.00–3.92) | F(6, 209.520) = 1.410; P = 0.212 | |
Post psychological intervention | 2.22 (1.62–2.81) | 2.19 (1.52–2.86) | 3.42 (2.07–4.76) | ||
After surgery | 123.93 (94.24–153.62) | 101.71 (77.65–125.76) | 96.14 (76.91–115.38) | ||
Follow-up (after 6 months) | 4.23 (2.05–6.42) | 4.17 (1.96–6.38) | 2.33 (1.54–3.12) |